- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06417424
Observe Intestinal Tract Cleaness of Senile Constipation Patients Used Gastrointestinal External Stimulation
May 12, 2024 updated by: Shanghai East Hospital
A Prospective, Randomized, Double-blind Controlled Clinical Study of Observation the Effect of Gastrointestinal External Stimulation on Intestinal Tract Cleaness in Patients With Senile Constipation
This is a prospective, randomized, double-blind controlled trial.
Elderly patients with constipation requiring colonoscopy were randomly divided into four groups: 1. Received both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation; 2. Received gastrointestinal external stimulation singly; 3. Received transcutaneouselectrical acupoint stimulation singly; 4. No stimulation was given.
All groups received oral administration of polyethylene glycol for intestinal cleansing.
Boston Bowel Preparation Scale (BBPS) score was used to assess the quality of intestinal cleanliness , with a total score of 9, and higher scores indicating better intestinal cleanliness, and BBPS≥6 was defined effective.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The early detection of intestinal lesions is extremely important, and the quality of intestine cleanliness is an important factor for the quality of colonoscopy.
The elderly are at high risk of intestinal diseases.
However, surveys have found that the overall quality of bowel cleanliness in elderly patients undergoing colonoscopy is poor, which affects the detection rate of colon lesions.
This is a prospective, randomized, double-blind, controlled clinical trial to observe whether combined gastrointestinal surface stimulation and transcutaneous electrical acupoint stimulation can improve the quality of bowel cleansing and increase the detection rate of intestinal diseases.
Elderly patients with constipation requiring colonoscopy were randomly divided into four groups: 1. Received both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation; 2. Received gastrointestinal external stimulation singly; 3. Received transcutaneouselectrical acupoint stimulation singly; 4. No stimulation was given.
All groups received oral administration of polyethylene glycol for intestinal cleansing.
Boston Bowel Preparation Scale (BBPS) score was used to assess the quality of intestinal cleanliness , with a total score of 9, and higher scores indicating better intestinal cleanliness, and BBPS≥6 was defined effective.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pudong New Area
-
Shanghai, Pudong New Area, China, 200120
- Recruiting
- Shanghai easthospital
-
Contact:
- Lan Zhong, MD
- Phone Number: +86-13162099450
- Email: lanzhong@tongji.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 60-80 years old;
- Colonoscopy was planned;
- The diagnosis of constipation was in accordance with Rome Ⅳ criteria.
Exclusion Criteria:
- Acute myocardial infarction (within 6 months), severe heart failure (New York Heart Association class II-V, chronic renal failure (CKD stage II-V), or mental disorder;
- Colorectal resection;
- Drugs of aspirin, warfarin, or other anticoagulants, and coagulopathy;
- Oral administration any drugs that may affect gastrointestinal motility, such as proton pump inhibitors, non-steroidal anti-inflammatory drugs or antibiotics (within 4 weeks), probiotics (within 2 weeks);
- The following diseases:inflammatory bowel disease, frequent diarrhea, severe gastroparesis, intestinal perforation or obstruction;
- Participating in other clinical trials.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: experimental group 1
Received both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation for 3 days, and then oral administration of polyethylene glycol for intestinal cleansing.
|
We used the device Gastrointestinal multifunctional therapeutic instrument.
The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.
|
Experimental: experimental group 2
Received gastrointestinal external stimulation singly, and then oral administration of polyethylene glycol for intestinal cleansing.
|
We used the device Gastrointestinal multifunctional therapeutic instrument.
The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.
|
Experimental: experimental group 3
Received transcutaneouselectrical acupoint stimulation singly, and then oral administration of polyethylene glycol for intestinal cleansing.
|
We used the device Gastrointestinal multifunctional therapeutic instrument.
The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.
|
No Intervention: Control
No stimulation was given.
Oral administration of polyethylene glycol for intestinal cleansing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Boston Bowel Preparation Scale (BBPS)
Time Frame: 1 year
|
Boston Bowel Preparation Scale (BBPS) score was used to assess the quality of intestinal cleanliness , with a total score of 9, and higher scores indicating better intestinal cleanliness, and BBPS≥6 was defined effective.
|
1 year
|
The positive rate of intestinal diseases
Time Frame: 1 year
|
The positive rate of intestinal diseases including polyps, adenoma, adenocarcinoma, enteritis, inflammatory bowel disease,diverticulum and so on by electronic colonoscopy.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse reactions
Time Frame: 1 year
|
The adverse reactions included abdominal distension, pain, nausea, vomiting, and fatigue.
|
1 year
|
Willingness to repeat
Time Frame: 1 year
|
The Likert scale was used to judge willingness to repeat the same interventions of intestinal cleansing in future electronic colonoscopies.
|
1 year
|
Gut microbiome alterations
Time Frame: 1 year
|
Collected fresh fecal samples before and 3 days after electrical stimulation, high-throughput sequencing was used to detect intestinal microbiome , analyzed the changes .
|
1 year
|
Gastrointestinal hormone
Time Frame: 1 year
|
The serum levels of gastrointestinal hormones including substance P, motilin,ghrelin,growth hormone, neurotensin and vasoactive intestinal peptide were measured before and after intervention.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2024
Primary Completion (Estimated)
March 31, 2025
Study Completion (Estimated)
May 31, 2025
Study Registration Dates
First Submitted
January 30, 2024
First Submitted That Met QC Criteria
May 12, 2024
First Posted (Actual)
May 16, 2024
Study Record Updates
Last Update Posted (Actual)
May 16, 2024
Last Update Submitted That Met QC Criteria
May 12, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DFSC-2023(CR)-077
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electric Stimulation
-
University of ZurichUniversity Hospital Inselspital, BerneRecruitingTranscranial Magnetic Stimulation | Electric Stimulation TherapySwitzerland
-
University Hospital, SaarlandCompletedElectric Stimulation Therapy
-
Bryn LloydInstitute for Biomedical Engineering, Swiss Federal Institute of Technology...CompletedElectric Stimulation | Peripheral Nerve Stimulation in MRISwitzerland
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreNot yet recruitingLung Transplantation | Electric StimulationBrazil
-
Heidelberg UniversityRechbergklinik BrettenTerminatedPercutaneous Electric Nerve StimulationGermany
-
Hospital de Clinicas de Porto AlegreUnknownLung Transplantation | Clinical Trial | Electric StimulationBrazil
-
University of Sao PauloCompletedElectric Stimulation Therapy | Pelvic Floor | Muscle | ContractionBrazil
-
Liberate MedicalTerminatedRespiration, Artificial | Ventilator Weaning | Electric StimulationUnited States
-
Taipei Medical UniversityCompletedHeart Rate | Transcutaneous Electric Nerve StimulationTaiwan
-
Universidad Complutense de MadridCompletedOrthognathic Surgery | Physiology | Transcutaneous Electric Nerve StimulationSpain
Clinical Trials on gastrointestinal external stimulation
-
Rosenblum, Jonathan I., DPMCompletedPeripheral Vascular DiseaseUnited States
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La Sapienza; Università degli studi di Roma Foro ItalicoUnknownParkinson Disease | Rehabilitation | Locomotion Disorder, Neurologic | Rhythm; AbnormalItaly
-
NeuroSigma, Inc.Olive View-UCLA Education & Research InstituteUnknownSeizure DisorderUnited States
-
Giresun UniversityCompletedUrinary Incontinence | Urinary Incontinence, Stress | Pelvic Floor Disorders | Electrical StimulationTurkey
-
Butler HospitalUniversity of North Carolina, Chapel Hill; Neurolief Ltd.Enrolling by invitation
-
Cairo UniversityUnknownDiabetic Peripheral Neuropathy
-
University of AarhusMedtronicCompletedIrritable Bowel SyndromeDenmark
-
Seoul National University HospitalCompletedCardiovascular Diseases | Cardiac ArrhythmiaKorea, Republic of
-
Cardialen, Inc.Iqvia Pty LtdTerminatedAtrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationUnited States
-
HsiuYun ChangCompletedParkinson DiseaseTaiwan